Considering that TDP-43 mislocalization and aggregation occurs in roughly 45% of the cases of frontotemporal dementia (FTD), we were curious to see if the anti-Trp68 antibody would show immunoreactivity in post-mortem cases of this disease (30). This evidence concerns the gene TARDBP and frontotemporal dementia.